Mangia, A., Francavilla, R., Merola, V., Barbaríni, G., Russello, M., Nosotti, L., et al. (2012). Benefit of weight bosed dosoges of Ribavirin (RBV) in combinotion with Peg-lnterferon (PeglFN) a2a in naive patients with HCV2 and HCV3: results of an ltalian Randomized Controlled Triol, the WRITE study. In Hepatology (pp.1001 A-1001 A). Elsevier Science Limited.
Benefit of weight bosed dosoges of Ribavirin (RBV) in combinotion with Peg-lnterferon (PeglFN) a2a in naive patients with HCV2 and HCV3: results of an ltalian Randomized Controlled Triol, the WRITE study
MONTALTO, Giuseppe;
2012-01-01
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
AASLD.pdf
Solo gestori archvio
Dimensione
1.2 MB
Formato
Adobe PDF
|
1.2 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
